UniProt ID | PDPK1_HUMAN | |
---|---|---|
UniProt AC | O15530 | |
Protein Name | 3-phosphoinositide-dependent protein kinase 1 | |
Gene Name | PDPK1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 556 | |
Subcellular Localization |
Cytoplasm. Nucleus. Cell membrane Peripheral membrane protein. Cell junction, focal adhesion. Tyrosine phosphorylation seems to occur only at the cell membrane. Translocates to the cell membrane following insulin stimulation by a mechanism that invo |
|
Protein Description | Serine/threonine kinase which acts as a master kinase, phosphorylating and activating a subgroup of the AGC family of protein kinases. Its targets include: protein kinase B (PKB/AKT1, PKB/AKT2, PKB/AKT3), p70 ribosomal protein S6 kinase (RPS6KB1), p90 ribosomal protein S6 kinase (RPS6KA1, RPS6KA2 and RPS6KA3), cyclic AMP-dependent protein kinase (PRKACA), protein kinase C (PRKCD and PRKCZ), serum and glucocorticoid-inducible kinase (SGK1, SGK2 and SGK3), p21-activated kinase-1 (PAK1), protein kinase PKN (PKN1 and PKN2). Plays a central role in the transduction of signals from insulin by providing the activating phosphorylation to PKB/AKT1, thus propagating the signal to downstream targets controlling cell proliferation and survival, as well as glucose and amino acid uptake and storage. Negatively regulates the TGF-beta-induced signaling by: modulating the association of SMAD3 and SMAD7 with TGF-beta receptor, phosphorylating SMAD2, SMAD3, SMAD4 and SMAD7, preventing the nuclear translocation of SMAD3 and SMAD4 and the translocation of SMAD7 from the nucleus to the cytoplasm in response to TGF-beta. Activates PPARG transcriptional activity and promotes adipocyte differentiation. Activates the NF-kappa-B pathway via phosphorylation of IKKB. The tyrosine phosphorylated form is crucial for the regulation of focal adhesions by angiotensin II. Controls proliferation, survival, and growth of developing pancreatic cells. Participates in the regulation of Ca(2+) entry and Ca(2+)-activated K(+) channels of mast cells. Essential for the motility of vascular endothelial cells (ECs) and is involved in the regulation of their chemotaxis. Plays a critical role in cardiac homeostasis by serving as a dual effector for cell survival and beta-adrenergic response. Plays an important role during thymocyte development by regulating the expression of key nutrient receptors on the surface of pre-T cells and mediating Notch-induced cell growth and proliferative responses. Provides negative feedback inhibition to toll-like receptor-mediated NF-kappa-B activation in macrophages. Isoform 3 is catalytically inactive.. | |
Protein Sequence | MARTTSQLYDAVPIQSSVVLCSCPSPSMVRTQTESSTPPGIPGGSRQGPAMDGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLTAYLPAMSEDDEDCYGNYDNLLSQFGCMQVSSSSSSHSLSASDTGLPQRSGSNIEQYIHDLDSNSFELDLQFSEDEKRLLLEKQAGGNPWHQFVENNLILKMGPVDKRKGLFARRRQLLLTEGPHLYYVDPVNKVLKGEIPWSQELRPEAKNFKTFFVHTPNRTYYLMDPSGNAHKWCRKIQEVWRQRYQSHPDAAVQ | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
4 | Phosphorylation | ----MARTTSQLYDA ----CCCCHHHHHHC | 22.66 | 21945579 | |
5 | Phosphorylation | ---MARTTSQLYDAV ---CCCCHHHHHHCC | 14.66 | 21945579 | |
6 | Phosphorylation | --MARTTSQLYDAVP --CCCCHHHHHHCCC | 19.99 | 21945579 | |
9 | Phosphorylation | ARTTSQLYDAVPIQS CCCHHHHHHCCCCCC | 8.33 | 21945579 | |
16 | Phosphorylation | YDAVPIQSSVVLCSC HHCCCCCCEEEEEEC | 26.31 | 21945579 | |
17 | Phosphorylation | DAVPIQSSVVLCSCP HCCCCCCEEEEEECC | 10.40 | 21945579 | |
22 | Phosphorylation | QSSVVLCSCPSPSMV CCEEEEEECCCHHHE | 25.54 | 21945579 | |
25 | Phosphorylation | VVLCSCPSPSMVRTQ EEEEECCCHHHEEEE | 33.65 | 21945579 | |
27 | Phosphorylation | LCSCPSPSMVRTQTE EEECCCHHHEEEECC | 33.96 | 21945579 | |
31 | Phosphorylation | PSPSMVRTQTESSTP CCHHHEEEECCCCCC | 28.56 | 29396449 | |
33 | Phosphorylation | PSMVRTQTESSTPPG HHHEEEECCCCCCCC | 36.90 | 23911959 | |
35 | Phosphorylation | MVRTQTESSTPPGIP HEEEECCCCCCCCCC | 42.79 | 25159151 | |
36 | Phosphorylation | VRTQTESSTPPGIPG EEEECCCCCCCCCCC | 38.41 | 25159151 | |
37 | Phosphorylation | RTQTESSTPPGIPGG EEECCCCCCCCCCCC | 42.66 | 25159151 | |
45 | Phosphorylation | PPGIPGGSRQGPAMD CCCCCCCCCCCCCCC | 27.61 | 29396449 | |
54 | Phosphorylation | QGPAMDGTAAEPRPG CCCCCCCCCCCCCCC | 20.59 | 28348404 | |
64 | Phosphorylation | EPRPGAGSLQHAQPP CCCCCCCCCCCCCCC | 25.07 | 28348404 | |
83 | Ubiquitination | KKRPEDFKFGKILGE CCCCCCCCCCCCCCC | 66.58 | 29967540 | |
88 | Ubiquitination | DFKFGKILGEGSFST CCCCCCCCCCCCCHH | 6.10 | 21890473 | |
92 | Phosphorylation | GKILGEGSFSTVVLA CCCCCCCCCHHHHHH | 16.24 | 28857561 | |
92 | Ubiquitination | GKILGEGSFSTVVLA CCCCCCCCCHHHHHH | 16.24 | 22817900 | |
94 | Phosphorylation | ILGEGSFSTVVLARE CCCCCCCHHHHHHHH | 23.22 | 20071362 | |
95 | Phosphorylation | LGEGSFSTVVLAREL CCCCCCHHHHHHHHH | 16.78 | 28122231 | |
111 | Ubiquitination | TSREYAIKILEKRHI HCHHHHHHHHHHHHC | 32.82 | 29967540 | |
114 (in isoform 4) | Phosphorylation | - | 52.06 | 19664994 | |
118 (in isoform 4) | Phosphorylation | - | 5.82 | 17081983 | |
123 | Ubiquitination | RHIIKENKVPYVTRE HHCHHCCCCCEEECC | 45.75 | 29967540 | |
126 | Phosphorylation | IKENKVPYVTRERDV HHCCCCCEEECCCHH | 19.90 | 22817900 | |
130 | Ubiquitination | KVPYVTRERDVMSRL CCCEEECCCHHHHHC | 43.82 | 32015554 | |
148 | Phosphorylation | FFVKLYFTFQDDEKL EEEEEEEEECCCCEE | 13.56 | 19835603 | |
156 | Phosphorylation | FQDDEKLYFGLSYAK ECCCCEEEEEEEECC | 13.48 | 25884760 | |
160 | Phosphorylation | EKLYFGLSYAKNGEL CEEEEEEEECCCCHH | 24.35 | 19835603 | |
161 | Phosphorylation | KLYFGLSYAKNGELL EEEEEEEECCCCHHH | 27.00 | 19835603 | |
170 | Phosphorylation | KNGELLKYIRKIGSF CCCHHHHHHHHHCCC | 13.11 | 20068231 | |
176 | Phosphorylation | KYIRKIGSFDETCTR HHHHHHCCCCCHHHH | 32.76 | 20068231 | |
177 | Ubiquitination | YIRKIGSFDETCTRF HHHHHCCCCCHHHHH | 9.20 | 21890473 | |
177 | Acetylation | YIRKIGSFDETCTRF HHHHHCCCCCHHHHH | 9.20 | 19608861 | |
177 | Ubiquitination | YIRKIGSFDETCTRF HHHHHCCCCCHHHHH | 9.20 | 21890473 | |
180 | Phosphorylation | KIGSFDETCTRFYTA HHCCCCCHHHHHHHH | 22.48 | 20068231 | |
181 | Ubiquitination | IGSFDETCTRFYTAE HCCCCCHHHHHHHHH | 2.12 | 22817900 | |
182 | Phosphorylation | GSFDETCTRFYTAEI CCCCCHHHHHHHHHH | 31.09 | 20068231 | |
188 | Ubiquitination | CTRFYTAEIVSALEY HHHHHHHHHHHHHHH | 35.80 | 29967540 | |
191 | Phosphorylation | FYTAEIVSALEYLHG HHHHHHHHHHHHHCC | 32.56 | 20068231 | |
195 | Phosphorylation | EIVSALEYLHGKGII HHHHHHHHHCCCCCC | 12.59 | 20068231 | |
196 | Ubiquitination | IVSALEYLHGKGIIH HHHHHHHHCCCCCCC | 2.91 | 29967540 | |
210 | Ubiquitination | HRDLKPENILLNEDM CCCCCHHHEEECCCC | 38.44 | 29967540 | |
211 | Ubiquitination | RDLKPENILLNEDMH CCCCHHHEEECCCCE | 4.40 | 21890473 | |
215 | Ubiquitination | PENILLNEDMHIQIT HHHEEECCCCEEEEC | 57.59 | 22817900 | |
231 | Phosphorylation | FGTAKVLSPESKQAR CCCEEECCHHHHHHH | 29.61 | 27067055 | |
234 | Phosphorylation | AKVLSPESKQARANS EEECCHHHHHHHHHC | 33.19 | 26074081 | |
235 | Ubiquitination | KVLSPESKQARANSF EECCHHHHHHHHHCC | 46.44 | 29967540 | |
241 | Phosphorylation | SKQARANSFVGTAQY HHHHHHHCCCCCCCC | 21.96 | 19664994 | |
245 | Phosphorylation | RANSFVGTAQYVSPE HHHCCCCCCCCCCHH | 12.80 | 22322096 | |
248 | Phosphorylation | SFVGTAQYVSPELLT CCCCCCCCCCHHHHC | 10.63 | 30266825 | |
250 | Phosphorylation | VGTAQYVSPELLTEK CCCCCCCCHHHHCCH | 14.02 | 30266825 | |
255 | Phosphorylation | YVSPELLTEKSACKS CCCHHHHCCHHCCCC | 54.73 | 23927012 | |
257 | Ubiquitination | SPELLTEKSACKSSD CHHHHCCHHCCCCHH | 37.81 | 32015554 | |
277 | Ubiquitination | CIIYQLVAGLPPFRA HHHHHHHHCCCCCCC | 23.54 | 21890473 | |
277 (in isoform 2) | Ubiquitination | - | 23.54 | 21890473 | |
278 (in isoform 3) | Ubiquitination | - | 31.10 | 21890473 | |
281 | Ubiquitination | QLVAGLPPFRAGNEY HHHHCCCCCCCCCCE | 36.08 | 22817900 | |
288 | Phosphorylation | PFRAGNEYLIFQKII CCCCCCCEEEEEEEH | 14.75 | 27642862 | |
296 | Acetylation | LIFQKIIKLEYDFPE EEEEEEHHCCCCCCH | 38.45 | 26051181 | |
299 | Phosphorylation | QKIIKLEYDFPEKFF EEEHHCCCCCCHHHC | 33.06 | 27642862 | |
304 | Acetylation | LEYDFPEKFFPKARD CCCCCCHHHCHHHHH | 53.17 | 23954790 | |
304 | Ubiquitination | LEYDFPEKFFPKARD CCCCCCHHHCHHHHH | 53.17 | 22817900 | |
304 (in isoform 1) | Ubiquitination | - | 53.17 | 21890473 | |
306 | Ubiquitination | YDFPEKFFPKARDLV CCCCHHHCHHHHHHH | 10.06 | 21890473 | |
308 | Ubiquitination | FPEKFFPKARDLVEK CCHHHCHHHHHHHHH | 51.39 | 22817900 | |
310 | Ubiquitination | EKFFPKARDLVEKLL HHHCHHHHHHHHHHH | 43.87 | 22817900 | |
314 | Ubiquitination | PKARDLVEKLLVLDA HHHHHHHHHHHHHHH | 45.33 | 29967540 | |
315 | Ubiquitination | KARDLVEKLLVLDAT HHHHHHHHHHHHHHH | 39.37 | 29967540 | |
323 | Ubiquitination | LLVLDATKRLGCEEM HHHHHHHHHHCCHHC | 47.55 | 29967540 | |
333 | Phosphorylation | GCEEMEGYGPLKAHP CCHHCCCCCCCCCCC | 11.41 | 27642862 | |
337 | Ubiquitination | MEGYGPLKAHPFFES CCCCCCCCCCCCCCC | 48.02 | 29967540 | |
338 | Ubiquitination | EGYGPLKAHPFFESV CCCCCCCCCCCCCCC | 24.22 | 21890473 | |
342 | Ubiquitination | PLKAHPFFESVTWEN CCCCCCCCCCCCHHH | 8.90 | 22817900 | |
342 | Ubiquitination | PLKAHPFFESVTWEN CCCCCCCCCCCCHHH | 8.90 | 21890473 | |
344 | Phosphorylation | KAHPFFESVTWENLH CCCCCCCCCCHHHHH | 21.49 | 20873877 | |
346 | Phosphorylation | HPFFESVTWENLHQQ CCCCCCCCHHHHHCC | 36.02 | 20873877 | |
354 | Phosphorylation | WENLHQQTPPKLTAY HHHHHCCCCCCEEEE | 34.68 | 20873877 | |
366 | Phosphorylation | TAYLPAMSEDDEDCY EEEECCCCCCCCCCC | 39.72 | 27251275 | |
368 | Ubiquitination | YLPAMSEDDEDCYGN EECCCCCCCCCCCCC | 58.24 | 29967540 | |
373 | Phosphorylation | SEDDEDCYGNYDNLL CCCCCCCCCCHHHHH | 22.26 | 20643654 | |
376 | Phosphorylation | DEDCYGNYDNLLSQF CCCCCCCHHHHHHHH | 11.22 | 18024423 | |
382 | Ubiquitination | NYDNLLSQFGCMQVS CHHHHHHHHCCEEEC | 38.43 | 29967540 | |
389 | Phosphorylation | QFGCMQVSSSSSSHS HHCCEEECCCCCCCC | 13.96 | 27251275 | |
390 | Phosphorylation | FGCMQVSSSSSSHSL HCCEEECCCCCCCCC | 35.07 | 27251275 | |
391 | Phosphorylation | GCMQVSSSSSSHSLS CCEEECCCCCCCCCC | 27.08 | 27251275 | |
392 | Phosphorylation | CMQVSSSSSSHSLSA CEEECCCCCCCCCCH | 37.50 | 26657352 | |
393 | Phosphorylation | MQVSSSSSSHSLSAS EEECCCCCCCCCCHH | 33.74 | 26657352 | |
394 | Phosphorylation | QVSSSSSSHSLSASD EECCCCCCCCCCHHH | 21.02 | 22817900 | |
396 | Phosphorylation | SSSSSSHSLSASDTG CCCCCCCCCCHHHCC | 26.43 | 15743829 | |
398 | Phosphorylation | SSSSHSLSASDTGLP CCCCCCCCHHHCCCC | 28.83 | 22817900 | |
408 | Phosphorylation | DTGLPQRSGSNIEQY HCCCCCCCCCCHHHH | 41.13 | 24719451 | |
410 | Phosphorylation | GLPQRSGSNIEQYIH CCCCCCCCCHHHHHH | 35.56 | 26074081 | |
415 | Phosphorylation | SGSNIEQYIHDLDSN CCCCHHHHHHCCCCC | 6.34 | 19690332 | |
441 | Ubiquitination | EKRLLLEKQAGGNPW HHHHHHHHHCCCCCC | 45.47 | 29967540 | |
485 | Phosphorylation | LTEGPHLYYVDPVNK HCCCCEEEEECCCCH | 9.82 | 11481331 | |
486 | Phosphorylation | TEGPHLYYVDPVNKV CCCCEEEEECCCCHH | 12.53 | - | |
495 | Ubiquitination | DPVNKVLKGEIPWSQ CCCCHHHCCCCCCCC | 58.44 | 29967540 | |
495 | Malonylation | DPVNKVLKGEIPWSQ CCCCHHHCCCCCCCC | 58.44 | 26320211 | |
501 | Phosphorylation | LKGEIPWSQELRPEA HCCCCCCCCCCCCCC | 14.39 | 19664994 | |
509 | Ubiquitination | QELRPEAKNFKTFFV CCCCCCCCCCCEEEE | 62.34 | 29967540 | |
513 | Phosphorylation | PEAKNFKTFFVHTPN CCCCCCCEEEEECCC | 20.40 | 21082442 | |
529 | Phosphorylation | TYYLMDPSGNAHKWC EEEEECCCCCHHHHH | 40.18 | 21082442 | |
534 | Acetylation | DPSGNAHKWCRKIQE CCCCCHHHHHHHHHH | 45.65 | 7704099 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
9 | Y | Phosphorylation | Kinase | INSR | P06213 | Uniprot |
9 | Y | Phosphorylation | Kinase | RET | P07949 | PSP |
9 | Y | Phosphorylation | Kinase | SRC64 | - | PhosphoELM |
9 | Y | Phosphorylation | Kinase | SRC | P12931 | Uniprot |
25 | S | Phosphorylation | Kinase | PDPK1 | O15530 | PhosphoELM |
25 | S | Phosphorylation | Kinase | PDK1 | Q15118 | GPS |
64 | S | Phosphorylation | Kinase | PKCT | Q04759 | PSP |
241 | S | Phosphorylation | Kinase | PDPK1 | O15530 | PhosphoELM |
241 | S | Phosphorylation | Kinase | PDK1 | Q15118 | GPS |
241 | S | Phosphorylation | Kinase | PKCT | Q04759 | PSP |
354 | T | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
354 | T | Phosphorylation | Kinase | MELK | Q61846 | PSP |
354 | T | Phosphorylation | Kinase | MELK | Q14680 | Uniprot |
373 | Y | Phosphorylation | Kinase | SRC | P12931 | Uniprot |
373 | Y | Phosphorylation | Kinase | SRC64 | - | PhosphoELM |
373 | Y | Phosphorylation | Kinase | INSR | P06213 | Uniprot |
373 | Y | Phosphorylation | Kinase | IGF1R | P08069 | PSP |
376 | Y | Phosphorylation | Kinase | SRC | P12931 | Uniprot |
376 | Y | Phosphorylation | Kinase | SRC64 | - | PhosphoELM |
376 | Y | Phosphorylation | Kinase | IGF1R | P08069 | PSP |
376 | Y | Phosphorylation | Kinase | INSR | P06213 | Uniprot |
393 | S | Phosphorylation | Kinase | PDPK1 | O15530 | PhosphoELM |
393 | S | Phosphorylation | Kinase | PDK1 | Q15118 | GPS |
394 | S | Phosphorylation | Kinase | ASK1 | Q99683 | PSP |
396 | S | Phosphorylation | Kinase | PDPK1 | O15530 | PhosphoELM |
396 | S | Phosphorylation | Kinase | PDK1 | Q15118 | GPS |
398 | S | Phosphorylation | Kinase | ASK1 | Q99683 | PSP |
410 | S | Phosphorylation | Kinase | PDPK1 | O15530 | PhosphoELM |
410 | S | Phosphorylation | Kinase | PDK1 | Q15118 | GPS |
501 | S | Phosphorylation | Kinase | PRKCQ | Q04759 | Uniprot |
513 | T | Phosphorylation | Kinase | PDPK1 | O15530 | PhosphoELM |
513 | T | Phosphorylation | Kinase | PDK1 | Q15118 | GPS |
529 | S | Phosphorylation | Kinase | PRKCQ | Q04759 | Uniprot |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PDPK1_HUMAN !! |
Kegg Disease | |
---|---|
There are no disease associations of PTM sites. | |
OMIM Disease | |
There are no disease associations of PTM sites. | |
Kegg Drug | |
There are no disease associations of PTM sites. | |
DrugBank | |
DB00482 | Celecoxib |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-304, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"PDK1 phosphorylation at Thr354 by murine protein serine/threoninekinase 38 contributes to the negative regulation of PDK1 activity."; Seong H.A., Jung H., Manoharan R., Ha H.; J. Biol. Chem. 0:0-0(2012). Cited for: PHOSPHORYLATION AT THR-354 BY MELK, PHOSPHORYLATION AT SER-394 ANDSER-398 BY MAP3K5, AND MUTAGENESIS OF THR-354; SER-394 AND SER-398. | |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-241, AND MASSSPECTROMETRY. | |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-35 AND SER-241, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-37 AND SER-241, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-241, AND MASSSPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-37 AND SER-241, AND MASSSPECTROMETRY. | |
"Phosphoproteomic analysis of the human pituitary."; Beranova-Giorgianni S., Zhao Y., Desiderio D.M., Giorgianni F.; Pituitary 9:109-120(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-241, AND MASSSPECTROMETRY. | |
"Phosphoinositide-dependent phosphorylation of PDK1 regulates nucleartranslocation."; Scheid M.P., Parsons M., Woodgett J.R.; Mol. Cell. Biol. 25:2347-2363(2005). Cited for: PHOSPHORYLATION AT SER-396, AND SUBCELLULAR LOCATION. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-241, AND MASSSPECTROMETRY. | |
"Identification of tyrosine phosphorylation sites on 3-phosphoinositide-dependent protein kinase-1 (PDK1) and their role inregulating kinase activity."; Park J., Hill M.M., Hess D., Brazil D.P., Hofsteenge J.,Hemmings B.A.; J. Biol. Chem. 276:37459-37471(2001). Cited for: PHOSPHORYLATION AT TYR-9; SER-241; TYR-373 AND TYR-376, ANDMUTAGENESIS OF TYR-9; TYR-373 AND TYR-376. | |
"Phosphorylation of Ser-241 is essential for the activity of 3-phosphoinositide-dependent protein kinase-1: identification of fivesites of phosphorylation in vivo."; Casamayor A., Morrice N.A., Alessi D.R.; Biochem. J. 342:287-292(1999). Cited for: PHOSPHORYLATION AT SER-25; SER-241; SER-393; SER-396 AND SER-410, ANDMUTAGENESIS OF SER-25; SER-241; SER-393; SER-396 AND SER-410. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-245, AND MASSSPECTROMETRY. | |
"Tyrosine phosphorylation of phosphoinositide-dependent kinase 1 bythe insulin receptor is necessary for insulin metabolic signaling."; Fiory F., Alberobello A.T., Miele C., Oriente F., Esposito I.,Corbo V., Ruvo M., Tizzano B., Rasmussen T.E., Gammeltoft S.,Formisano P., Beguinot F.; Mol. Cell. Biol. 25:10803-10814(2005). Cited for: PHOSPHORYLATION AT TYR-9; TYR-373 AND TYR-376 BY INSR, AND INTERACTIONWITH INSR. | |
"Pyk2- and Src-dependent tyrosine phosphorylation of PDK1 regulatesfocal adhesions."; Taniyama Y., Weber D.S., Rocic P., Hilenski L., Akers M.L., Park J.,Hemmings B.A., Alexander R.W., Griendling K.K.; Mol. Cell. Biol. 23:8019-8029(2003). Cited for: FUNCTION, PHOSPHORYLATION AT TYR-9; TYR-373 AND TYR-376 BY SRC,INTERACTION WITH PTK2B, AND SUBCELLULAR LOCATION. |